CILENT
Phase 1 Completed
32 enrolled
Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
Phase 2 Completed
18 enrolled 5 charts
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Phase 2 Completed
5 enrolled 10 charts
Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Phase 2 Completed
23 enrolled 10 charts
Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride
Phase 1 Completed
12 enrolled
PT2385
Phase 2 Completed
24 enrolled 11 charts
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Phase 1 Completed
23 enrolled
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
24 enrolled
AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Phase 1 Completed
44 enrolled
NRR
Phase 2 Completed
501 enrolled 14 charts
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
7 enrolled
Irinotecan in Treating Asian Patients With Solid Tumors
Phase 1 Completed
18 enrolled
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Phase 1 Completed
21 enrolled
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Completed
180 enrolled
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Phase 1 Completed
12 enrolled
White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors
Phase 1 Completed
16 enrolled
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Phase 1 Completed
13 enrolled
FOLFERA
Phase 2 Completed
111 enrolled
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
Phase 2 Completed
47 enrolled